NACDS Total Store Expo to Feature FDA Presentation on New Supply Chain Law

Published Online: Tuesday, July 8, 2014
Follow Pharmacy_Times:

July 8, 2014, Arlington, Va. – A unique opportunity to learn directly from the Food and Drug Administration (FDA) about the implications of the Drug Supply Chain Security Act of 2014 awaits the attendees of the National Association of Chain Drug Stores (NACDS) Total Store Expo next month. Dr. Ilisa B.G. Bernstein, deputy director of the Office of Compliance with the FDA Center for Drug Evaluation and Research, will conduct a presentation on the implementation of the law during the four-day trade show and strategic exchange in Boston, Massachusetts.

Dr. Bernstein will speak on Sunday, August 24 at 10:00 a.m. during the Insight Session “Drug Supply Chain Security Act: Overview and Implementation.” As 2015 approaches in just a few short months, manufacturers, distributors and supply chain partners are preparing for new phases of implementation of the law. Dr. Bernstein’s Insight Session will provide clarity to the many deadlines, definitions and intricacies associated with the implementation process of the new law for pharmacies, manufacturers, distributors and supply chain partners.

“Dr. Bernstein’s presentation at the NACDS Total Store Expo is not only timely, but also demonstrates the depth and breadth of what this trade show provides for NACDS members and the industry,” said NACDS President and CEO Steven C. Anderson, IOM, CAE. “NACDS has made it a top priority to continue to advocate and to present education opportunities related to the new supply chain law’s implementation. The NACDS Total Store Expo presents an ideal opportunity to help deliver on that objective.”

Each NACDS Total Store Expo Insight Session is carefully crafted to ensure that attendees are receiving helpful information to conduct business on a day-to-day basis on a variety of issues and priorities including healthcare, business and logistics. In fact, many of the sessions – including Dr. Bernstein’s session - may provide crossover into other segments of the industry where both retailers and suppliers benefit from the presentation. To date, 18 Insight Sessions are scheduled during the trade show.

The NACDS Total Store Expo will take place August 23-26 at the Boston Convention & Exhibition Center.
Related Articles
The National Association of Chain Drug Stores lends its support to S. 483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
The value of collaboration through the National Association of Chain Drug Stores was on display today, as the NACDS Regional Chain Conference explored business-to-business partnerships and a public policy agenda that benefits patients and consumers.
A proposal in the Budget of the U.S. Government, Fiscal Year 2016 to increase prescription drug co-payments for TRICARE beneficiaries met with concern by the National Association of Chain Drug Stores.
Bipartisan legislation introduced in the U.S. Senate today would formally designate pharmacists as healthcare providers under Medicare Part B. Supported by the National Association of Chain Drug Stores (NACDS), the bill would amend The Social Security Act of 1935 to enable pharmacists to provide to Medicare patients in underserved communities services that pharmacists already are providing for other patients under state law.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times